Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.
Martínez-Frías
María-Luisa
ML
D000014:Abnormalities, Drug-Induced / Q000000981:diagnostic imaging / Q000453:epidemiology* / Q000517:prevention & control; D000927:Anticonvulsants / Q000009:adverse effects*; D004249:DNA Damage / Q000187:drug effects / Q000235:genetics; D005260:Female; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives*; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D007230:Infant, Low Birth Weight / Q000378:metabolism; D007231:Infant, Newborn; D009152:Mutagenicity Tests; D009436:Neural Tube Defects / Q000201:enzymology / Q000235:genetics / Q000503:physiopathology; D010353:Patient Education as Topic; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology*; D018570:Risk Assessment; D000077236:Topiramate; D016216:Ultrasonography, Prenatal / Q000592:standards; D014635:Valproic Acid / Q000009:adverse effects
D000927:Anticonvulsants; D056572:Histone Deacetylase Inhibitors; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid; D006655:Histone Deacetylases